Kui Jiang
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
-
- Advanced Breast Cancer Therapies 2
- Prostate Cancer Treatment and Research 2
- Oncology 9
- PARP inhibition in cancer therapy 4
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Liping Fang (3 shared papers)Yue Wang (1 shared paper)Min Wang (2 shared papers)Xiaolin Sang (2 shared papers)Pixu Liu (2 shared papers)Hailing Cheng (2 shared papers)Jingyan Yi (1 shared paper)Zhiwei Tao (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)OncoTargets and Therapy (2 papers)Annals of Oncology (2 papers)Oncotarget (2 papers)International Journal of Gynecological Cancer (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Kui Jiang
21 papers receiving 341 citations
Peers
Comparison fields: 5 of 55
- Reproductive Medicine 50
- Cancer Research 80
- Oncology 92
- Microbiology 21
- Molecular Biology 163
Countries citing papers authored by Kui Jiang
This map shows the geographic impact of Kui Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kui Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kui Jiang more than expected).
Fields of papers citing papers by Kui Jiang
This network shows the impact of papers produced by Kui Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kui Jiang. The network helps show where Kui Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kui Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 60 | |
| 2 | 2022 | 53 | |
| 3 | 2016 | 44 | |
| 4 | 2021 | 41 | |
| 5 | 2018 | 30 | |
| 6 | 2022 | 23 | |
| 7 | 2018 | 20 | |
| 8 | 2017 | 16 | |
| 9 | 2015 | 12 | |
| 10 | 2022 | 9 | |
| 11 | 2019 | 7 | |
| 12 | 2022 | 5 | |
| 13 | 2024 | 5 | |
| 14 | 2024 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2021 | 3 | |
| 17 | 2024 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2024 | 1 |
About Kui Jiang
Kui Jiang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Reproductive Medicine, Molecular Biology and Epidemiology, having authored 23 papers that have together received 347 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (8 papers), PARP inhibition in cancer therapy (4 papers), Cancer, Lipids, and Metabolism (2 papers), Advanced Breast Cancer Therapies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), Epigenetics and DNA Methylation (2 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Reproductive Medicine (50 citations), Cancer Research (80 citations), Oncology (92 citations), Microbiology (21 citations) and Molecular Biology (163 citations). Kui Jiang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Liping Fang, Yue Wang, Min Wang, Xiaolin Sang, Pixu Liu, Hailing Cheng, Jingyan Yi, Zhiwei Tao, Fuwen Luo and Lingying Wu. Their work appears in journals such as Journal of Clinical Oncology, OncoTargets and Therapy, Annals of Oncology, Oncotarget and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.